Delivery Order SPE2DB24D2010-SPE2DB25FZXV1
- Not listed
- The Defense Logistics Agency awarded a $12,869.67 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections), a brand-name pharmaceutical product used in osteoporosis treatment. The contract is a firm fixed-price delivery order with an ultimate completion date of May 19, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $54,040.80 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 ml pen injections), a pharmaceutical product used to treat osteoporosis. The contract is a firm fixed price delivery order with no set-aside designation, issued on July 31, 2025, with an ultimate completion date of August 1, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $12,499.08 to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 ml pen injections) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. FORTEO is an FDA-approved pharmaceutical treatment for osteoporosis and bone-related conditions, commonly utilized within military and...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (fortified with 560 mcg/2.24 mL pen injections). The contract, which became effective on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Conshohocken facility....
- The Defense Logistics Agency awarded a $19,378.19 delivery order to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, which utilized no set-aside designation, was issued under a firm fixed-price contract structure and represents a single delivery order for pharmaceutical supplies to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. FORTEO is a bone-building...
- The Defense Logistics Agency awarded a $6,492.02 delivery order to AmerisourceBergen Drug Corp for FORTEO (forteoide) 560 mcg/2.24 mL pen injections on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order to be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. FORTEO is a prescription injectable medication commonly used in the treatment of osteoporosis...
- The Defense Logistics Agency awarded a $14,640.18 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections) on April 24, 2025, with completion scheduled for April 25, 2025. This competitive award utilizes firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $3,392.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of FORTEO (560 mcg/2.24 mL pen injections). This is a non-set-aside contract with an ultimate completion date of August 4, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. FORTEO is a prescription medication used primarily for treating osteoporosis in patients at high risk for fractures. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injection) with a ceiling value of $8,274.44. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,220.43 for FORTEO 560 mcg/2.24 mL pen injections on June 3, 2025, with completion targeted for June 4, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio. The product will be performed at the company's corporate office location in Conshohocken,...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FZXV1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $47,923.50 to AmerisourceBergen Drug Corp for the supply of FORTEO (560 mcg/2.24 mL pen injection), a pharmaceutical treatment for osteoporosis. The contract, awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, was issued without a set-aside designation under a firm fixed price arrangement. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The contract was competitively awarded and reflects AmerisourceBergen's established capability as a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems managed by the Defense Health Agency and other government entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.9k | 4/21/25 |